These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5357543)

  • 1. [General remarks on Rifampicin].
    Toscano F
    Minerva Med; 1969 Dec; 60(96):4783-9. PubMed ID: 5357543
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():243-58. PubMed ID: 7009395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin. Interactions with other drugs].
    Salvá JA; Erill S
    Arch Farmacol Toxicol; 1975 Mar; 1(1):82-90. PubMed ID: 1231650
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of experimental staphylococcal mastitis in the mouse with cloxacillin and rifampicin, alone and in combination.
    Craven N; Anderson JC
    Res Vet Sci; 1981 Nov; 31(3):295-300. PubMed ID: 6919178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of rifampicin on non-tubercular bacterial flora].
    Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):41-50. PubMed ID: 5405841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation between lipophilic character and antibacterial activity of rifampicin: results in liquid and solid media].
    Barbaro AM; Guerra MC; Biagi GL
    Boll Soc Ital Biol Sper; 1971 Oct; 47(19):556-8. PubMed ID: 5140767
    [No Abstract]   [Full Text] [Related]  

  • 9. Causes for rifampicin toxicity--experimental study.
    Zítková L; Stastná J; Dobrovský K; Tousek J
    Czech Med; 1982; 5(4):210-7. PubMed ID: 6818008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on antibiotic therapy. 2) Rifampicin].
    Di Nola F
    Minerva Med; 1982 Feb; 73(7):357-62. PubMed ID: 7188493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sex-related differences in the level of rifampicin in humans and animals].
    Zwolska-Kwiek Z
    Pneumonol Pol; 1982 Nov; 50(11):563-9. PubMed ID: 7182813
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings].
    Birmingham AT; Coleman AJ; Orme ML; Park BK; Pearson NJ; Short AH; Southgate PJ
    Br J Clin Pharmacol; 1978 Nov; 6(5):455P-456P. PubMed ID: 728306
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of rifampicin and tetracycline alone and in combination against Brucella suis.
    De Rycke J
    Ann Microbiol (Paris); 1980; 131B(3):277-87. PubMed ID: 7469256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of aminoglycosides and rifampicin upon bacteria from clinical specimens (author's transl)].
    Silva J; Herrera N; Becerra S; Jofré M; Gutiérrez A; Hannelore
    Rev Med Chil; 1981 Mar; 109(3):231-5. PubMed ID: 7280407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin, a new antitubercular bactericide].
    Thibault P
    Presse Med (1893); 1970 Feb; 78(11):501-2. PubMed ID: 5418624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin in the treatment of respiratory tract infections].
    Beeuwkes H; Buytendijk HJ; Maesen F
    Poumon Coeur; 1969; 25(5):507-20. PubMed ID: 5367621
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampin.
    Farr B; Mandell GL
    Med Clin North Am; 1982 Jan; 66(1):157-68. PubMed ID: 7038325
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent investigations on the biological properties of rifampicin.
    Furesz S
    Acta Tuberc Pneumol Belg; 1969; 60(3):266-9. PubMed ID: 5371663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of endotoxin on the pharmacokinetics of rifampicin in rabbits.
    Lefebvre R; Celeda L; Morávek J; Hofman J; Rasková H
    Physiol Bohemoslov; 1983; 32(4):382-4. PubMed ID: 6353451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.